Agios Pharmaceuticals, Inc. ( AGIO ) Q3 2026 Earnings Call November 5, 2026 8:00 AM EST Company Participants Morgan Sanford - Vice President of Investor Relations Brian Goff - CEO & Director Cecilia Jones - Chief Financial Officer Tsveta Milanova - Chief Commercial Officer Sarah Gheuens - Chief Medical Officer and Head of Research & Development Conference Call Participants Alec Stranahan - BofA Securities, Research Division Samantha Semenkow - Citigroup Inc., Research Division Eric Schmidt - Cantor Fitzgerald & Co., Research Division Anish Nikhanj - Truist Securities, Inc., Research Division Douglas Tsao - H.C. Wainwright & Co, LLC, Research Division Joseph Thome - TD Cowen, Research Division Tessa Romero - JPMorgan Chase & Co, Research Division Salveen Richter - Goldman Sachs Group, Inc., Research Division Luca Issi - RBC Capital Markets, Research Division Presentation Operator Good morning, and welcome to Agios Pharmaceuticals Third Quarter 2026 Conference Call.